DUPIXENT Asthma Tunnel
- Category HCP, Immunology, Respiratory
- Client Sanofi/Regeneron
- Date 2022
Pulms weren’t paying enough attention to type 2 inflammation, a major driver of asthma in up to 90% of patients. We got them to take notice with an experiential, motion-activated, video tunnel. It drew foot-traffic into our booth, while educating attendees on the various pathophysiological effects along the way. It was a highly effective booth draw, with over 8500 trips taken through it across 3 different conferences.